Effective Strategies for Pediatric Formulation Development

Published on: 


Thursday, November 17, 2022 at 10 am EDT | 9 am PDT | 6 am CDT In this webcast, panel speakers will discuss the unmet needs within the pediatric population, swallowability challenges related to children’s medications and strategies to optimize pediatric formulation development resulting in improved acceptability and patient treatment plans.

Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1579812&tp_key=9ecaa2e743

Event Overview:

Pediatric populations represent the most diverse patient groups in all of medicine. Factors such as individual preferences, physiology, and dosage considerations all serve to complicate drug formulation aimed at pediatric care. Drug formulation for children has become increasingly important as the healthcare field recognizes the huge impact that strict patient adherence can have on a treatment’s efficacy as well as how off-label administration of a therapy, more common among younger and older patients, can both decrease efficacy and create the potential for medication-related toxicities.

In this webcast, three panel speakers will discuss the unmet needs within the pediatric population and related clinical recommendations for pediatric dosage forms. Swallowability challenges and the impact to children’s medication, and strategies to optimize pediatric formulation development resulting in improved patient outcomes within the pediatric population will be discussed. Join the webinar to learn how you can apply these strategies for your products today.

Key Learning Objectives:

  • Learn about the unmet needs facing pediatric populations:
    • Dose Volume and Liquid Dose Measuring Challenges
    • Excipient Issues
  • Taste Masking for Pediatrics
    • Challenges Specific to Pediatric Formulation Development
    • Strategies and Solutions to Improve Patient Outcomes
  • Swallowability and Determining the Right Dosage Form
    • Swallowing Challenges Unique to Pediatrics
    • Current Solutions
    • Strategies for Improving Medication Acceptability


Rachel Meyers, PharmD, BCPS, BCPPS, FPPA
Clinical Professor
Ernest Mario School of Pharmacy,
Rutgers University

Rachel Meyers is a Clinical Professor at the Ernest Mario School of Pharmacy at Rutgers University, and the Pediatric Clinical Pharmacist at Cooperman Barnabas Medical Center in Livingston, New Jersey. Dr. Meyers completed her undergraduate degree at the University of Mary Washington and her Doctor of Pharmacy degree at the University of Connecticut. After graduation she completed a PGY-1 residency at the University of Wisconsin Hospital and Clinics in Madison, Wisconsin, and a PGY-2 residency in Pediatric Pharmacotherapy at the University of North Carolina Children’s Hospital in Chapel Hill, North Carolina. In her current position, Dr. Meyers provides both didactic and experiential education in pediatric pharmacotherapy for pharmacy students and residents. She practices in both the Pediatric Intensive Care Unit and General Pediatric Unit at Cooperman Barnabas Medical Center.

Srinivasan Shanmugam, PhD
Senior Director, Pharmaceutical
Sciences, Business Support, and
New Technologies
Adare Pharma Solutions

Dr. Shanmugam has more than 20 years of experience in designing and development of conventional, NDDS/alternate, advanced/modified drug delivery systems, and pharmaceutical platform technologies for oral and other routes of administration. His expertise includes stability, solubility/dissolution, permeability, and bioavailability enhancement techniques/technologies for challenging drugs. Additionally, Dr. Shanmugam has published numerous research articles, holds multiple patents, and is a reviewer/editorial member of various prestigious journals. In his current position, Dr. Shanmugam is involved in the development and expansion of Adare’s pharmaceutical technology portfolio and facilitates product development and co-development opportunities.

Dr. Luigi Boltri
Senior Director, Pharmaceutical
Adare Pharma Solutions

Dr. Boltri is a pharmaceutical chemist by training and completed his degree at the University of Turin.
With more than 30 years of experience in the Pharmaceutical Industry, Dr Boltri has held leading positions as Department Head and Director. Dr. Boltri has extensive experience in formulation development for various dosage forms, with a focus on oral delivery and bioavailability enhancement.

In the current role, Dr. Boltri supports Company processes leading to identify new and innovative technologies as well as valuable opportunities for product development and co-development.

Time and Date:

Thursday, November 17, 2022 at 10 am EDT | 9 am PDT | 6 am CDT


Adare Pharma Solutions

Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1579812&tp_key=9ecaa2e743